XML 34 R87.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Statements (Condensed Consolidating Statement Of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Intercompany fee income (expense) $ 0 $ 0 $ 0
Interest income (expense) on intercompany receivable/payable 0 0 0
Net cash provided (used) by other operating activities 231,439 196,101 185,668
Net operating cash provided by continuing operations 231,439 196,101 185,668
Cash Provided by (Used in) Operating Activities, Discontinued Operations 2,681 11,343 10,248
Net Cash Provided by (Used in) Operating Activities 234,120 207,444 195,916
Acquisition of rental properties and other assets (123,497) (73,188) (53,175)
Proceeds from sale of real estate 797 0 0
Investment in unconsolidated joint ventures (1,607) (1,800) (3,970)
Investment in mortgage notes receivable (60,568) (113,823) (19,688)
Proceeds from mortgage note receivable paydown 1,900 0 0
Investment in promissory notes receivable (1,278) 0 0
Proceeds from Sale and Collection of Notes Receivable 1,027 0 0
Investment in direct financing leases, net (3,262) 0 (2,113)
Proceeds from Sale of Lease Receivables 0 4,494 0
Additions to properties under development (197,271) (113,599) (57,926)
Investment in intercompany notes payable 0 0 0
Advances to subsidiaries, net 0 0 0
Net cash used by investing activities of continuing operations (383,759) (297,916) (136,872)
Net cash used by other investing activities of discontinued operations 0 0 (58)
Net proceeds from sale of real estate from discontinued operations 47,301 42,133 226,612
Net cash used by investing activities (336,458) (255,783) 89,682
Proceeds from long-term debt facilities 646,000 871,000 387,000
Principal payments on long-term debt (552,468) (658,571) (425,859)
Deferred financing fees paid (8,133) (5,800) (3,731)
Costs associated with loan refinancing or payoff (cash portion) (5,790) (189) (117)
Net proceeds from issuance of common shares 220,785 231 253
Net proceeds from issuance of preferred shares 0 120,567 0
Redemption of preferred shares 0 (115,013) (80,030)
Impact of stock option exercises, net 947 (1,987) 966
Purchase of common shares for treasury (3,246) (3,232) (3,070)
Dividends paid to shareholders (197,924) (162,775) (157,844)
Net cash provided by financing activities 100,171 44,231 (282,432)
Effect of exchange rate changes on cash (539) 147 (317)
Net increase (decrease) in cash and cash equivalents (2,706) (3,961) 2,849
Cash and cash equivalents at beginning of the year 10,664 14,625 11,776
Cash and cash equivalents at end of the year 7,958 10,664 14,625
EPR Properties (Issuer) [Member]
     
Intercompany fee income (expense) 2,629 2,706 2,726
Interest income (expense) on intercompany receivable/payable 17,848 16,967 16,665
Net cash provided (used) by other operating activities (38,183) (19,940) (12,924)
Net operating cash provided by continuing operations (17,706) (267) 6,467
Cash Provided by (Used in) Operating Activities, Discontinued Operations 0 0 0
Net Cash Provided by (Used in) Operating Activities (17,706) (267) 6,467
Acquisition of rental properties and other assets (1,358) (422) (603)
Proceeds from sale of real estate 0    
Investment in unconsolidated joint ventures (1,607) (1,800) (2,773)
Investment in mortgage notes receivable 11,797 0 0
Proceeds from mortgage note receivable paydown 0    
Investment in promissory notes receivable 0    
Proceeds from Sale and Collection of Notes Receivable 117    
Investment in direct financing leases, net 0   0
Proceeds from Sale of Lease Receivables   0  
Additions to properties under development (18) 0 0
Investment in intercompany notes payable 103,104 (3,074) 127,111
Advances to subsidiaries, net (386,759) (416,859) 108,495
Net cash used by investing activities of continuing operations (298,318) (422,155) 232,230
Net cash used by other investing activities of discontinued operations     0
Net proceeds from sale of real estate from discontinued operations 0 0 0
Net cash used by investing activities (298,318) (422,155) 232,230
Proceeds from long-term debt facilities 300,000 590,000 0
Principal payments on long-term debt 0 0 0
Deferred financing fees paid (5,620) (5,770) (396)
Costs associated with loan refinancing or payoff (cash portion) 0   0
Net proceeds from issuance of common shares 220,785 231 253
Net proceeds from issuance of preferred shares   120,567  
Redemption of preferred shares   115,013 80,030
Impact of stock option exercises, net 947 (1,987) 966
Purchase of common shares for treasury (3,246) (3,232) (3,070)
Dividends paid to shareholders (197,924) (162,775) (157,844)
Net cash provided by financing activities 314,942 422,021 (240,121)
Effect of exchange rate changes on cash 0 0 0
Net increase (decrease) in cash and cash equivalents (1,082) (401) (1,424)
Cash and cash equivalents at beginning of the year 1,531 1,932 3,356
Cash and cash equivalents at end of the year 449 1,531 1,932
Wholly-Owned Subsidiary Guarantors [Member]
     
Intercompany fee income (expense) 0 0 0
Interest income (expense) on intercompany receivable/payable 0 0 0
Net cash provided (used) by other operating activities 197,152 164,505 143,020
Net operating cash provided by continuing operations 197,152 164,505 143,020
Cash Provided by (Used in) Operating Activities, Discontinued Operations 286 1,036 7,947
Net Cash Provided by (Used in) Operating Activities 197,438 165,541 150,967
Acquisition of rental properties and other assets (94,119) (67,890) (46,822)
Proceeds from sale of real estate 0    
Investment in unconsolidated joint ventures 0 0 0
Investment in mortgage notes receivable 46,402 (90,975) (18,391)
Proceeds from mortgage note receivable paydown (202)    
Investment in promissory notes receivable 1,278    
Proceeds from Sale and Collection of Notes Receivable 0    
Investment in direct financing leases, net (3,262)   2,113
Proceeds from Sale of Lease Receivables   (4,494)  
Additions to properties under development (189,736) (99,924) (53,355)
Investment in intercompany notes payable 0 0 (132,074)
Advances to subsidiaries, net 188,458 445,612 (172,843)
Net cash used by investing activities of continuing operations (146,137) 191,317 (425,598)
Net cash used by other investing activities of discontinued operations     (58)
Net proceeds from sale of real estate from discontinued operations 0 282 205,936
Net cash used by investing activities (146,137) 191,599 (219,720)
Proceeds from long-term debt facilities 346,000 281,000 387,000
Principal payments on long-term debt (394,740) (638,684) (315,324)
Deferred financing fees paid (2,494) (6) (3,330)
Costs associated with loan refinancing or payoff (cash portion) 0 (37) 0
Net proceeds from issuance of common shares 0 0 0
Net proceeds from issuance of preferred shares   0  
Redemption of preferred shares   0 0
Impact of stock option exercises, net 0 0 0
Purchase of common shares for treasury 0 0 0
Dividends paid to shareholders 0 0 0
Net cash provided by financing activities (51,234) (357,727) 68,346
Effect of exchange rate changes on cash (13) (5) (166)
Net increase (decrease) in cash and cash equivalents 54 (592) (573)
Cash and cash equivalents at beginning of the year 651 1,243 1,816
Cash and cash equivalents at end of the year 705 651 1,243
Non-Guarantor Subsidiaries [Member]
     
Intercompany fee income (expense) (2,629) (2,706) (2,726)
Interest income (expense) on intercompany receivable/payable (17,848) (16,967) (16,665)
Net cash provided (used) by other operating activities 72,470 51,536 55,572
Net operating cash provided by continuing operations 51,993 31,863 36,181
Cash Provided by (Used in) Operating Activities, Discontinued Operations 2,395 10,307 2,301
Net Cash Provided by (Used in) Operating Activities 54,388 42,170 38,482
Acquisition of rental properties and other assets (28,020) (4,876) (5,750)
Proceeds from sale of real estate 797    
Investment in unconsolidated joint ventures 0 0 (1,197)
Investment in mortgage notes receivable 2,369 (22,848) (1,297)
Proceeds from mortgage note receivable paydown (1,698)    
Investment in promissory notes receivable 0    
Proceeds from Sale and Collection of Notes Receivable 910    
Investment in direct financing leases, net 0   0
Proceeds from Sale of Lease Receivables   0  
Additions to properties under development (7,517) (13,675) (4,571)
Investment in intercompany notes payable (103,104) 3,074 4,963
Advances to subsidiaries, net 198,301 (28,753) 64,348
Net cash used by investing activities of continuing operations 60,696 (67,078) 56,496
Net cash used by other investing activities of discontinued operations     0
Net proceeds from sale of real estate from discontinued operations 47,301 41,851 20,676
Net cash used by investing activities 107,997 (25,227) 77,172
Proceeds from long-term debt facilities 0 0 0
Principal payments on long-term debt (157,728) (19,887) (110,535)
Deferred financing fees paid (19) (24) (5)
Costs associated with loan refinancing or payoff (cash portion) (5,790) (152) (117)
Net proceeds from issuance of common shares 0 0 0
Net proceeds from issuance of preferred shares   0  
Redemption of preferred shares   0 0
Impact of stock option exercises, net 0 0 0
Purchase of common shares for treasury 0 0 0
Dividends paid to shareholders 0 0 0
Net cash provided by financing activities (163,537) (20,063) (110,657)
Effect of exchange rate changes on cash (526) 152 (151)
Net increase (decrease) in cash and cash equivalents (1,678) (2,968) 4,846
Cash and cash equivalents at beginning of the year 8,482 11,450 6,604
Cash and cash equivalents at end of the year $ 6,804 $ 8,482 $ 11,450